<p>(A) Anti-tumor effect. PTX is administered at a dose of 80 mg/kg. Six groups of mice were treated: Group 1: PBS injection (<i>n</i> = 6); Group 2: PTX-loaded micelles (<i>n</i> = 6); Group 3: Irradiation with 10 Gy of X-rays (<i>n</i> = 6); Group 4: PTX-loaded micelles 24 h before irradiation with 10 Gy of X-rays (<i>n</i> = 8); Group 5: PTX-loaded micelles 24 h before irradiation with 10 Gy of X-rays. The irradiated legs of mice were clamped (<i>n</i> = 7); Each point represents the mean of tumor size ± SEM. (B) Survival rates of tumor-bearing mice. (C) Individual evolution of the TLT growth as a function of time. ** <i>p</i><0.001; ***<i>p</i><0.0001.</p
PURPOSE: To investigate the effect of (191)Pt-cisplatin in vivo in terms of the antitumor effect and...
<p>(A) Tumor growth curve of TRAMP-C1 tumors growing subcutaneously in the thigh following various c...
<p>A) Palpable tumors developed in all control and paclitaxel treated animals, but not in the STX140...
<p>Mean tumor pO<sub>2</sub> (± SD) monitored by EPR oximetry. A. Mice treated with PTX-loaded micel...
<p>(A) Control mice (<i>n</i> = 3). (B) Mice treated 24 h before analysis with PTX-loaded micelles (...
<p>Tumor volume of xenograft mice treated with PTX (4 doses, twice a week, 18 mg/kg i.v.) or vehicle...
<p>Oxygen rate measured as function of time (mean ± SEM). Slope for treated mice (<i>n</i> = 3) sign...
<p>(A) Athymic nude mice were received subcutaneous injections with DLD-1 cells (2×10<sup>6</sup>), ...
<p>gPTX-IL (open circle with line), gPTX-L (open triangle), gPTX-L with trastuzumab (open square), t...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
A) Tumor growth curve of CG5 cells (1x106) co-injected i.m.in nude mice (5 mice/group) with ASCs (1x...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
<p>(A) Vaccination schedule of polyplex micelles encapsulating therapeutic genes (<a href="http://ww...
<p>(A) RD xenograft tumor growth curve in BALB/C nude mice. The mice were injected with the followin...
Docetaxel (taxotere; RP 56976) is twice as potent as taxol in the inhibition of microtubule depolyme...
PURPOSE: To investigate the effect of (191)Pt-cisplatin in vivo in terms of the antitumor effect and...
<p>(A) Tumor growth curve of TRAMP-C1 tumors growing subcutaneously in the thigh following various c...
<p>A) Palpable tumors developed in all control and paclitaxel treated animals, but not in the STX140...
<p>Mean tumor pO<sub>2</sub> (± SD) monitored by EPR oximetry. A. Mice treated with PTX-loaded micel...
<p>(A) Control mice (<i>n</i> = 3). (B) Mice treated 24 h before analysis with PTX-loaded micelles (...
<p>Tumor volume of xenograft mice treated with PTX (4 doses, twice a week, 18 mg/kg i.v.) or vehicle...
<p>Oxygen rate measured as function of time (mean ± SEM). Slope for treated mice (<i>n</i> = 3) sign...
<p>(A) Athymic nude mice were received subcutaneous injections with DLD-1 cells (2×10<sup>6</sup>), ...
<p>gPTX-IL (open circle with line), gPTX-L (open triangle), gPTX-L with trastuzumab (open square), t...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
A) Tumor growth curve of CG5 cells (1x106) co-injected i.m.in nude mice (5 mice/group) with ASCs (1x...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
<p>(A) Vaccination schedule of polyplex micelles encapsulating therapeutic genes (<a href="http://ww...
<p>(A) RD xenograft tumor growth curve in BALB/C nude mice. The mice were injected with the followin...
Docetaxel (taxotere; RP 56976) is twice as potent as taxol in the inhibition of microtubule depolyme...
PURPOSE: To investigate the effect of (191)Pt-cisplatin in vivo in terms of the antitumor effect and...
<p>(A) Tumor growth curve of TRAMP-C1 tumors growing subcutaneously in the thigh following various c...
<p>A) Palpable tumors developed in all control and paclitaxel treated animals, but not in the STX140...